Status:
COMPLETED
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
Lead Sponsor:
Allergan
Conditions:
Stroke
Muscle Spasticity
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety of injections of botulinum toxin Type A in patients with reduced lung function and focal upper limb poststroke spasticity
Eligibility Criteria
Inclusion
- Abnormal pulmonary function test results;
- focal, upper limb spasticity, upper motor neuron syndrome
Exclusion
- Previous exposure to botulinum toxin of any serotype
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
155 Patients enrolled
Trial Details
Trial ID
NCT00076687
Start Date
October 1 2003
End Date
August 1 2009
Last Update
October 3 2011
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Miami, Florida, United States
2
Prague, Czechia
3
Szeged, Hungary
4
Warsaw, Poland